1
|
Krylova T, Itkis Y, Tsygankova P, Chistol D, Lyamzaev K, Tabakov V, Mikhaylova S, Nikitina N, Rudenskaya G, Murtazina A, Markova T, Semenova N, Buchinskaya N, Saifullina E, Aksyanova H, Sparber P, Andreeva N, Venediktova N, Ivanushkina A, Eliseeva D, Murakhovskaya Y, Sheremet N, Zakharova E. Exploring the Phenotypic Heterogeneity and Bioenergetic Profile of the m.13513G>A mtDNA Substitution: A Heteroplasmy Perspective. Int J Mol Sci 2025; 26:4565. [PMID: 40429710 PMCID: PMC12111569 DOI: 10.3390/ijms26104565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2025] [Revised: 04/23/2025] [Accepted: 04/29/2025] [Indexed: 05/29/2025] Open
Abstract
The m.13513G>A (p.Asp393Asn) substitution in the MT-ND5 (Mitochondrially Encoded NADH/Ubiquinone Oxidoreductase Core Subunit 5) gene is a common pathogenic variant associated with primary mitochondrial disorders. It frequently causes Leigh syndrome and mitochondrial encephalomyopathy with lactate acidosis and stroke-like episodes (MELAS). In this study, we present clinical data, heteroplasmy levels in various tissues (blood, urine, and skin fibroblasts), and bioenergetic characteristics from a cohort of 20 unrelated patients carrying the m.13513G>A mutation, classified according to the following phenotypes: Leigh syndrome (n = 12), MELAS (n = 2), and Leber's hereditary optic neuropathy (LHON, n = 6). We observed a significant correlation between high respiratory ratios and heteroplasmy levels in fibroblast cell lines of the patients. Furthermore, fibroblast cell lines with heteroplasmy levels exceeding 55% exhibited markedly reduced mitochondrial membrane potential. These findings contribute to a better understanding of the clinical and bioenergetic profiles of patients with m.13513G>A-variant-related phenotypes across different heteroplasmy levels, based on data from a single genetic center. Our data suggest that even a slight shift in heteroplasmy can improve cellular function and, consequently, the patients' phenotype, providing a solid foundation for the development of future gene therapies for mtDNA diseases.
Collapse
Affiliation(s)
| | - Yulia Itkis
- Research Centre for Medical Genetics, 115522 Moscow, Russia
| | | | - Denis Chistol
- Research Centre for Medical Genetics, 115522 Moscow, Russia
| | - Konstantin Lyamzaev
- Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia;
- The “Russian Clinical Research Center for Gerontology” of the Ministry of Healthcare of the Russian Federation, Pirogov Russian National Research Medical University, 129226 Moscow, Russia
| | | | | | - Natalia Nikitina
- State Autonomous Healthcare Institution of the Sverdlovsk Region «Clinical and Diagnostic Center ‘‘Maternal and Child Health Protection’’», 620041 Ekaterinburg, Russia
| | | | | | | | | | - Natalia Buchinskaya
- Saint-Petersburg State Medical Diagnostic Center (Genetic Medical Center), 194044 Saint-Petersburg, Russia
| | - Elena Saifullina
- Department of Medical Genetics and Fundamental Medicine, Bashkir State Medical University, 450008 Ufa, Russia
| | - Hasyanya Aksyanova
- State Budgetary Healthcare Institution of Nizhny Novgorod Region «Nizhny Novgorod Regional Children’s Clinical Hospital», 603005 Nizhny Novgorod, Russia
| | - Peter Sparber
- Research Centre for Medical Genetics, 115522 Moscow, Russia
| | | | | | - Alina Ivanushkina
- Saint-Petersburg State Budgetary Healthcare Institution City Clinic No. 14, 194021 Saint-Petersburg, Russia
| | | | - Yulia Murakhovskaya
- I.M. Sechenov First Moscow State Medical University, the Department of Ophthalmology, 119991 Moscow, Russia
| | | | | |
Collapse
|
2
|
Veeraragavan S, Johansen M, Johnston IG. Evolution and maintenance of mtDNA gene content across eukaryotes. Biochem J 2024; 481:1015-1042. [PMID: 39101615 PMCID: PMC11346449 DOI: 10.1042/bcj20230415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2024] [Revised: 06/26/2024] [Accepted: 07/18/2024] [Indexed: 08/06/2024]
Abstract
Across eukaryotes, most genes required for mitochondrial function have been transferred to, or otherwise acquired by, the nucleus. Encoding genes in the nucleus has many advantages. So why do mitochondria retain any genes at all? Why does the set of mtDNA genes vary so much across different species? And how do species maintain functionality in the mtDNA genes they do retain? In this review, we will discuss some possible answers to these questions, attempting a broad perspective across eukaryotes. We hope to cover some interesting features which may be less familiar from the perspective of particular species, including the ubiquity of recombination outside bilaterian animals, encrypted chainmail-like mtDNA, single genes split over multiple mtDNA chromosomes, triparental inheritance, gene transfer by grafting, gain of mtDNA recombination factors, social networks of mitochondria, and the role of mtDNA dysfunction in feeding the world. We will discuss a unifying picture where organismal ecology and gene-specific features together influence whether organism X retains mtDNA gene Y, and where ecology and development together determine which strategies, importantly including recombination, are used to maintain the mtDNA genes that are retained.
Collapse
Affiliation(s)
| | - Maria Johansen
- Department of Mathematics, University of Bergen, Bergen, Norway
| | - Iain G. Johnston
- Department of Mathematics, University of Bergen, Bergen, Norway
- Computational Biology Unit, University of Bergen, Bergen, Norway
| |
Collapse
|